Why the study?
Secondary prevention of sudden cardiac death in young patients with arrhythmogenic right ventricular cardiomyopathy and hemodynamically tolerated ventricular tachycardia remains challenging.
Does a combined approach of subcutaneous ICD and catheter ablation prevent ventricular tachycardia recurrences and ICD shocks in young patients with arrhythmogenic right ventricular cardiomyopathy?
Does a combined approach of subcutaneous ICD and catheter ablation prevent ventricular tachycardia recurrences and ICD shocks in young patients with arrhythmogenic right ventricular cardiomyopathy?
A combined approach of subcutaneous ICD and catheter ablation may be a promising strategy for secondary prevention of sudden cardiac death in young patients with ARVC and tolerated VT.
Combined S-ICD plus ablation may avoid shocks in select young ARVC patients with tolerated VT; hypothesis-generating and requires prospective validation.
Secondary prevention of sudden cardiac death in the young patient with arrhythmogenic right ventricular cardiomyopathy and hemodynamically tolerated ventricular tachycardia is still a challenging field. We present a combined approach, including subcutaneous implantable cardioverter-defibrillator (ICD) and catheter ablation, as a promising treatment to prevent both ventricular tachycardia recurrences and ICD shocks. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Sanniti et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: